Taiwan Liposome Company, Ltd. Operating Expense
Taiwan Liposome Company, Ltd. reported Operating Expense of TWD 1.11 billion for the 12-month period ending 2020-12-31, per its 20-F filed 2021-03-30.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2021-03-30
TWD
| Period end | Operating Expense 12 month |
|---|---|
| 2020-12-31 | 1.11B TWD 20-F · filed 2021-03-30 |
| 2019-12-31 | 1.03B TWD 20-F · filed 2021-03-30 |
| 2018-12-31 | 980.32M TWD 20-F · filed 2021-03-30 |
| 2017-12-31 | 948.12M TWD 20-F · filed 2020-03-10 |
| 2016-12-31 | 878.37M TWD 20-F · filed 2019-04-30 |
USD
| Period end | Operating Expense 12 month |
|---|---|
| 2020-12-31 | $39.65M 20-F · filed 2021-03-30 |
| 2019-12-31 | $34.33M 20-F · filed 2020-03-10 |
| 2018-12-31 | $32.03M 20-F · filed 2019-04-30 |